MEDICOX Statistics

Total Valuation

MEDICOX has a market cap or net worth of KRW 19.78 billion. The enterprise value is 26.04 billion.

Market Cap	19.78B
Enterprise Value	26.04B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

MEDICOX has 58.87 million shares outstanding. The number of shares has increased by 74.66% in one year.

Current Share Class	n/a
Shares Outstanding	58.87M
Shares Change (YoY)	+74.66%
Shares Change (QoQ)	+2.62%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	42.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.51
PB Ratio	0.35
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.88
EV / Sales	0.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.33

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 0.37.

Current Ratio	0.81
Quick Ratio	0.65
Debt / Equity	0.37
Debt / EBITDA	n/a
Debt / FCF	-1.80
Interest Coverage	-4.60

Financial Efficiency

Return on equity (ROE) is -47.96% and return on invested capital (ROIC) is -11.81%.

Return on Equity (ROE)	-47.96%
Return on Assets (ROA)	-9.64%
Return on Capital (ROIC)	-11.81%
Revenue Per Employee	370.79M
Profits Per Employee	-380.48M
Employee Count	78
Asset Turnover	0.31
Inventory Turnover	15.05

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.55% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-71.55%
50-Day Moving Average	391.94
200-Day Moving Average	602.08
Relative Strength Index (RSI)	43.19
Average Volume (20 Days)	1,821,412

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MEDICOX had revenue of KRW 28.92 billion and -29.68 billion in losses. Loss per share was -679.47.

Revenue	28.92B
Gross Profit	1.46B
Operating Income	-14.60B
Pretax Income	-27.34B
Net Income	-29.68B
EBITDA	-12.02B
EBIT	-14.60B
Loss Per Share	-679.47

Full Income Statement

Balance Sheet

The company has 13.91 billion in cash and 20.17 billion in debt, giving a net cash position of -6.26 billion or -106.31 per share.

Cash & Cash Equivalents	13.91B
Total Debt	20.17B
Net Cash	-6.26B
Net Cash Per Share	-106.31
Equity (Book Value)	54.44B
Book Value Per Share	952.73
Working Capital	-4.78B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.79 billion and capital expenditures -396.21 million, giving a free cash flow of -11.19 billion.

Operating Cash Flow	-10.79B
Capital Expenditures	-396.21M
Free Cash Flow	-11.19B
FCF Per Share	-190.02

Full Cash Flow Statement

Margins

Gross margin is 5.06%, with operating and profit margins of -50.47% and -102.62%.

Gross Margin	5.06%
Operating Margin	-50.47%
Pretax Margin	-94.54%
Profit Margin	-102.62%
EBITDA Margin	-41.58%
EBIT Margin	-50.47%
FCF Margin	-38.68%

Dividends & Yields

MEDICOX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-74.66%
Shareholder Yield	-74.66%
Earnings Yield	-202.22%
FCF Yield	-56.55%

Stock Splits

The last stock split was on November 16, 2022. It was a forward split with a ratio of 2.

Last Split Date	Nov 16, 2022
Split Type	Forward
Split Ratio	2

Scores

MEDICOX has an Altman Z-Score of -0.91. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.91
Piotroski F-Score	n/a